OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026
Key Highlights
- ➤OPKO will report Q3 2026 operating and financial results November 4, 2026
- ➤Management will discuss results and financial guidance during a 4:30 p.m. ET call
- ➤OPKO develops multispecific antibodies, in vivo CAR-T, and long-acting therapeutics
MIAMI, Oct. 28, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a multinational biopharmaceutical company, today announced that it will report operating and financial results for the third quarter 2026 on Wednesday, November 4, 2026. OPKO’s senior management will host a conference call and webcast at 4:30 p.m. ET to provide a business update, discuss results and financial guidance.
OPKO encourages participants to pre-register for the conference call using this link. Participants who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed through OPKO’s Investor Relations here.
Get started
Create a free account to read the full story.
